Loading...
Nutex Health, Inc.
NUTX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$95.02
$-0.73(-0.77%)
Nutex Health, Inc. (NUTX) Financial Performance & Income Statement Overview
Review Nutex Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
93.80%
↑ 93.80%
Operating Income Growth
511.10%
↑ 511.10%
Net Income Growth
213.96%
↑ 213.96%
Operating Cash Flow Growth
1742.79%
↑ 1742.79%
Operating Margin
32.26%
↑ 32.26%
Gross Margin
48.77%
↑ 48.77%
Net Profit Margin
15.50%
↑ 15.50%
ROE
71.10%
↑ 71.10%
ROIC
34.40%
↑ 34.40%
Nutex Health, Inc. (NUTX) Income Statement & Financial Overview
Review Nutex Health, Inc.'s (NUTX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $257.62M | $78.79M | $76.08M | $67.45M |
| Cost of Revenue | $115.99M | $56.88M | $53.52M | $57.30M |
| Gross Profit | $141.63M | $21.92M | $22.56M | $10.16M |
| Gross Profit Ratio | $0.55 | $0.28 | $0.30 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $27.43M | $11.83M | $10.59M | $8.71M |
| Operating Expenses | $27.42M | $12.25M | $17.26M | $8.71M |
| Total Costs & Expenses | $143.41M | $69.13M | $70.78M | $66.004M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.05M | $5.38M | $5.05M | $4.44M |
| Depreciation & Amortization | $5.28M | $4.97M | $4.53M | $4.19M |
| EBITDA | $118.91M | $7.77M | $13.49M | $8.48M |
| EBITDA Ratio | $0.46 | $0.10 | $0.18 | $0.13 |
| Operating Income | $114.21M | $9.66M | $5.30M | $1.45M |
| Operating Income Ratio | $0.44 | $0.12 | $0.07 | $0.02 |
| Other Income/Expenses (Net) | -$5.63M | -$12.24M | -$1.39M | -$1.60M |
| Income Before Tax | $108.58M | -$2.58M | $3.90M | -$152822.00 |
| Income Before Tax Ratio | $0.42 | -$0.03 | $0.05 | -$0.002 |
| Income Tax Expense | $8.61M | $4.58M | $893892.00 | $389665.00 |
| Net Income | $61.70M | -$8.79M | -$364048.00 | -$364075.00 |
| Net Income Ratio | $0.24 | -$0.11 | -$0.005 | -$0.005 |
| EPS | $11954.48 | -$1723.19 | -$0.07 | -$0.08 |
| Diluted EPS | $11954.48 | -$1723.19 | -$0.07 | -$0.08 |
| Weighted Avg Shares Outstanding | $5.10M | $5.10M | $4.97M | $4.85M |
| Weighted Avg Shares Outstanding (Diluted) | $5.10M | $5.10M | $4.97M | $4.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan